LIMERICK, Pa., Mar 25, 2011 (BUSINESS WIRE) --
Teleflex Incorporated (NYSE:TFX), a global provider of medical
technology products, announced a global distribution agreement with
Perouse Medical under which Teleflex will distribute the Perouse line of
POLYSITE(R) intravenous implantable infusion ports.
With this agreement, Teleflex complements its Arrow vascular access
product lines with a range of implantable infusion ports used for
facilitating the administration of chemotherapeutics, related
medications and fluids. The POLYSITE family, an established brand
currently available in several European countries, includes a full range
of port sizes, designs and catheter types. Perouse Medical is an
innovative French company with over 30 years of experience, specializing
in the development, manufacturing and distribution of medical devices
used in Oncology, Cardiovascular and interventional imaging.
Teleflex expects to begin distribution in additional European markets in
the current quarter and to expand distribution to other global markets,
pending appropriate regulatory approvals.
Through its Arrow brand, Teleflex is one of the leading global providers
of catheter-based vascular access solutions. The Arrow family of
products includes the ARROWg+ard Blue PLUS(R) central venous catheters
with Chlorhexidine-based technology and the recently introduced Arrow
EVOLUTION(TM) PICC with Chlorag+ard(TM) antimicrobial technology. Central
venous access catheters, peripherally inserted central catheters, multi
access catheters and acute hemodialysis catheters are now available in
ErgoPack Maximal Barrier Precautions Trays, a system designed to support
compliance with best practice and guidelines for catheter insertion.
Teleflex also recently expanded its vascular access product offerings
with the acquisition of the VasoNova(TM) VPS(TM), vascular positioning system,
a central venous catheter tip navigation system.
About Perouse Medical
For more information, visit www.perousemedical.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Limerick, PA,
Teleflex employs approximately 11,750 people worldwide and serves
healthcare providers in more than 130 countries. The company also has
niche businesses which produce specialty engineered products for the
aerospace market. For additional information about Teleflex please refer
to www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Vice President Investor Relations
610-948-2836